Author Correction: EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas

Abstract

Figures

Invert and fluorescent microscope images of GFP transfection efficiency of GFP gene expression in (a) YM1 and (b) KYSE-30 cells. Fluorescent microscopy images of GFP control cells 24 h after transfection.Fig. 6(a) WB Image analysis with the G-Box gel documentation system. (b) WB analysis confirmed high level of E-cad protein experssion in EZH2-ectopic cells. B-actin antibodies was used as a control. (c) Positive staining corresponds to Iimmunocytochemistry staining of E-cad and Zeb2 protein (dark brown is strong positive). (d) patologist score to E-cad and Zeb2 protein expersion via Immunocyto

c, where the GFP control and certain ICC images were mislabelled due to an unintentional error by the photography operator during image preparation.

Full text

Correction to: Scientific Reports 10.1038/s41598-022-23253-2, published online 31 October 2022

The original version of this Article contained an error in Figure 1 and Figure 6c, where the GFP control and certain ICC images were mislabelled due to an unintentional error by the photography operator during image preparation.

The original Figure 1 and Figure 6 and accompanying legend appear below.Fig. 1. Invert and fluorescent microscope images of GFP transfection efficiency of GFP gene expression in (a) YM1 and (b) KYSE-30 cells. Fluorescent microscopy images of GFP control cells 24 h after transfection.Fig. 6(a) WB Image analysis with the G-Box gel documentation system. (b) WB analysis confirmed high level of E-cad protein experssion in EZH2-ectopic cells. B-actin antibodies was used as a control. (c) Positive staining corresponds to Iimmunocytochemistry staining of E-cad and Zeb2 protein (dark brown is strong positive). (d) patologist score to E-cad and Zeb2 protein expersion via Immunocytochemistry assay (3 is srongly positive) (Supplementary Information).

The original Article has been corrected.